Microbes living in your digestive tract may help you achieve or maintain a healthy body weight by influencing your food intake behaviors. This article delves into what scientists know and do not know about gut microbiota and obesity and provides science-backed tools for leveraging the microbes in your gut to achieve a healthier body weight.
Dysosmobacter welbionis as potential promising next-generation probiotic for improving metabolic health?
8 May 2024by Patrice D. Cani
Dysosmobacter welbionis is a typical inhabitant of the human gut. New findings suggest it could be a potential next-generation beneficial bacterium for tackling specific cardiometabolic disorders linked to obesity and type 2 diabetes.
Reduced red meat intake and gut microbial metabolite indole-3-acetate linked to better insulin resistance after gastric bypass, new study finds
8 Jan 2024by Joël Doré, Andreu Prados
The gut microbiome has been involved in reducing adiposity in patients with obesity after gastric bypass. New research suggests that food intake, tryptophan metabolism, and gut microbiota composition can explain the glycemic improvement observed in patients after Roux-en-Y gastric bypass.
Are we ready to target the gut microbiota for obesity and weight management? A journey from bench to bedside
24 May 2023by Andreu Prados, Patrice D. Cani
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
Pasteurized Akkermansia muciniphila: a new bacterium to fight metabolic syndrome?
26 May 2022by GMFH Editing Team
Prof. Patrice D. Cani updates the health effects of Akkermansia muciniphila as one of the most widely studied gut bacteria for weight management.
The potential benefits of fecal microbiota transplantation in obesity could rely on supplementation of low-fermentable fiber
25 Oct 2021by GMFH Editing Team
Fecal microbiota transplantation is being studied in the context of metabolic health, beyond its use for recurrent Clostridioides difficile infection. A new proof-of-principle study reveals that supplementing low-fermentable fiber following fecal microbiota transplantation may improve insulin sensitivity in individuals with severe obesity.
A new gut bacterium common in healthy people offers promise for obesity
21 Jul 2021by GMFH Editing Team
We have known for a while that obesity has a microbial component. Now, a team of scientists led by Patrice D. Cani reports a novel bacterium isolated from the human gut that counteracts diet-induced obesity, inflammation and glucose dysregulation in mice.
A newly isolated human butyrate-producing bacterium might counteract some features of obesity
12 Jul 2021by Patrice D. Cani
The gut microbiome is a potential target of interest for scientists in managing obesity and related metabolic diseases. Scientists have isolated a new-bacterium highly prevalent in the human gut and showing benefits for host metabolism.
Is it time to consider next-generation beneficial microbes for tackling obesity?
15 Feb 2021by Andreu Prados
Is it time to consider next-generation beneficial microbes for tackling obesity? APC Microbiome Ireland researchers identify Bifidobacterium longum APC1472 as a promising candidate
2020 at a glance: A year of important scientific progress in gut microbiome research
1 Feb 2021by GMFH Editing Team
In 2020, we saw important scientific advances in our understanding of how the gut microbiome contributes to human health beyond the gastrointestinal milieu. Discover the year’s breakthroughs in this “2020 Year at a glance” report.
